GlassScriptPhysician profile
Charles L Pucevich
NPI 1942299383
$3,921.55
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,947 · 2020: $709 · 2021: $1,082 · 2022: $183.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $770.83 | 2019-2021 | |
| Amgen INC. | $653.36 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $506.92 | 2019-2021 | |
| Janssen Biotech, INC. | $345.24 | 2019-2021 | |
| Ucb, INC. | $285.90 | 2019-2021 | |
| Lilly USA, LLC | $202.58 | 2019-2021 | |
| Celgene Corporation | $160.12 | 2019 | |
| Mallinckrodt Hospital Products INC. | $127.23 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $124.99 | 2019 | |
| Aurinia Pharma U.S., INC. | $121.05 | 2021 | |
| Medexus Pharma, INC. | $118.53 | 2019 | |
| Janssen Scientific Affairs, LLC | $97.89 | 2022 | |
| Mallinckrodt Enterprises LLC | $92.00 | 2019 | |
| Glaxosmithkline, LLC. | $90.12 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $68.68 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $52.49 | 2019 | |
| Sobi, INC | $25.13 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.15 | 2021 | |
| Horizon Therapeutics Plc | $17.62 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Pucevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.